APA (7th ed.) Citation

AM, R., F, I., M, B., T, C., NC, G., P, C., . . . S, M. (2013). Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents. Leukemia & lymphoma, 54(5), 1117. https://doi.org/10.3109/10428194.2012.733879

Chicago Style (17th ed.) Citation

AM, Ronchetti, Isnard F, Buffet M, Coman T, Gorin NC, Coppo P, Garderet L, and Malak S. "Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Is an Effective Salvage Regimen for Multiple Myeloma Refractory to Novel Agents." Leukemia & Lymphoma 54, no. 5 (2013): 1117. https://doi.org/10.3109/10428194.2012.733879.

MLA (9th ed.) Citation

AM, Ronchetti, et al. "Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Is an Effective Salvage Regimen for Multiple Myeloma Refractory to Novel Agents." Leukemia & Lymphoma, vol. 54, no. 5, 2013, p. 1117, https://doi.org/10.3109/10428194.2012.733879.